Professional Documents
Culture Documents
We describe a rapid purification of protein kinase C from rat brain cytosol employing a specific substrate,
protamine-coupled to agarose. Sequential chromatography on DEAE-Sephacel, phenyl-Sepharose CL-4B, and
protamine-agarose columns resulted in a 1500-fold purification of protein kinase C. SDS-PAGE analysis of the
purified enzyme resolved a doublet protein of 77 - 80 kDa. This doublet was recognized by a polyclonal antiserum
against protein kinase C. Proteolytic digestion of each protein band generated similar peptide fragments.
The underlying principle of the protamine sulfate purification method was also clarified. Protamine can serve
as a Ca2+/phospholipid-independent substrate. We demonstrate phosphorylation of protamine on the column;
phosphorylated protamine did not bind the enzyme with the same affinity and this covalent modification was
most probably responsible for releasing the bound enzyme from the column after addition of Mg2+ and ATP.
The C kinase inhibitor, H7, inhibits protamine phosphorylation in a dose-dependent fashion but does not prevent
binding of the enzyme to a protamine-agarose column. We therefore conclude that protamine interacts with the
active center of the enzyme enabling it to be phosphorylated, upon which it loses its binding affinity for C kinase.
Protein kinase C has been shown to play a fundamental cation scheme and, if so, provide a molecular explanation
role in mediating the actions of hormones, neurotransmitters, for the event. We demonstrated the following: (a) protamine
and growth factors [l - 31. This enzyme has received consider- coupled to agarose could be used as an adjuvant step during
able attention since its activation is coupled to ligand-re- purification; (b) protamine phosphorylation was Ca2+/
ceptor-mediated phospholipid turnover [l]. Protein-kinase C phospholipid-independent but addition of Ca2+/phospho-
is predominantly cytosolic in a variety of cell types [l, 21 and lipid could further increase phosphorylation; (c) interaction
has a ubiquitous tissue distribution, with brain being one of with the substrate probably involved the active center in such
the richest sources [4]. Increases in intracellular calcium ion a way that protamine was phosphorylated, upon which the
partially activate the enzyme and promote translocation to the enzyme was released; (d) Ca2+/phospholipid-independent
plasma membrane [5, 61. Diacylglycerol, which is transiently phosphorylation of protamine could be inhibited by H7,
generated from hydrolysis of inositol 4,5-bisphosphate, fully confirming an inhibitory effect at the level of the active center;
activates the enzyme and together with phosphatidylserine and (e) previously described protamine kinase activity is hom-
provides an anchor to the membrane [l, 71. Since the initial ologous to protein kinase C activity.
purification of protein kinase C from rat brain [8] and bovine
heart [9], several schemes have been employed to obtain
homogeneous enzyme [lo - 141, the most commonly used EXPERIMENTAL PROCEDURE
method being that of Uchida [l11 utilizing phosphatidylserine
Materials
column chromatography. However, owing to either degrada-
tion of the enzyme or activation by copurifying Ca2+-depen- Histone (type 111-S), phosphatidylserine, diolein, pro-
dent proteases, these lengthy procedures have yielded low tamine sulfate and protamine-agarose were obtained from
quantities of enzyme. Although protamine sulfate has pre- Sigma. [y-32P]ATPwas purchased from Amersham. Phenyl-
viously been described as a protein kinase C substrate, which is Sepharose CL-4B was obtained from Pharmacia. DEAE-
phosphorylated in a Ca2+/phospholipid-independent manner Sephacel and Whatman 3MM paper were obtained from
[15], the specific mechanism for this event has remained an Whatman. Polyacrylamide gel electrophoresis, protein deter-
enigma. We were specifically interested to see whether pro- mination reagents and standard molecular mass markers were
tamine could be used as a step in developing an affinity purifi- from Bio-Rad. H7 was obtained from Seikagaku Kogyo Co.
and silver-stain reagents were from Accurate Chemical and
Correspondence to M. W. Wooten, Division of Hematology/ Scientific Co. All other reagents were of the highest purity
Oncology, Department of Medicine, University of Alabama at Bir- available.
mingham, University Station, Birmingham, Alabama, USA 35294
Abbreviations. H7, 1-(5-isoquinolinylsuIfonyl)-2-methylpipera-
zine dihidrochloride; PtdSer, phosphatidylserine; PhMeS02F, Preparation of crude extract
phenylmethylsulfonyl fluoride.
Enzymes. Protein kinase C (EC 2.7.1.37); V8 protease (EC 25 male Sprague Dawley rats (200-250 g) were deca-
3.4.21.19). pitated and cerebra rapidly removed. The tissue (40g, wet
462
I
10
Fraction number
106
1:
Froctian Number
I E
14oL
Fig. 1 F r o ~ t i o n number
463
weight) was homogenized in a Waring blender for 10 s with 8 Phenyl-Sepharose CL-4B column chromatography
volumes of buffer A (20 mM Tris/Cl, pH 7.4; 2 mM EDTA;
The pooled DEAE-Sephacel fractions were adjusted to the
10 mM EGTA; 250 mM sucrose; 1 mg/ml PhMeS02F;
conductivity of buffer D (20 mM Tris/Cl, pH 7.4; 0.5 mM
50 mM 2-mercaptoethanol; 250 U/ml aprotinin). The homog-
EDTA; 0.5 mM EGTA; 10 mM 2-mercaptoethanol (contain-
enate was centrifuged for 60 min at 100000 xg, after which ing 1.5 M NaCl and applied directly to a 5-ml washed and
the supernatant was collected, filtered through glass wool, packed phenyl-Sepharose CL-4B column at a flow rate of
and the pH adjusted to 7.6 with 1 M Tris/CI, pH 8.0.
60 ml/h. The column was washed with 50 ml buffer D 1.5 M +
NaCl at a flow rate of 125 ml/h followed by a 50-ml wash of
buffer D + 0.6 M NaCl at a flow rate of 50 ml/h. The column
DEAE-Sephacel fractionation was developed with a 30-ml linear gradient of 600-0 mM
NaCl in buffer D at a flow rate of 25 ml/h, followed by an
The crude extract (320 ml) was applied at a flow rate of
additional 30-ml wash of the buffer D alone. Fractions of
60 ml/h to a DEAE-Sephacel column (2.5 cm x 20 cm)
1 ml each were collected and assayed for protein kinase C
equilibrated with buffer B (20 mM Tris/Cl, pH 7.4; 5 mM
activity and the proteins eluted from the resin were analyzed
EGTA; 2 mM EDTA; 50 mM 2-mercaptoethanol). The
by SDS-PAGE.
column was washed with 200 ml of the same buffer and then
with 500 ml buffer C (20 mM Tris/Cl, pH 7.4; 1 mM EGTA;
1 mM EDTA; 50 mM 2-mercaptoethanol) at a flow rate of
Protamine-agarose column chromatography
125 ml/h. The enzyme was eluted from the column by a linear
gradient of 0 - 0.3 M NaCl in buffer C (600 ml) at a flow rate Protamine-agarose (1 ml) was pre-equilibrated in buffer E
of 60 ml/h. Fractions of 6 ml each were collected. Every fifth (20 mM Tris/CI, pH 7.4; 0.5 mM EDTA; 10 mM 2-mer-
fraction was assayed for protein kinase C activity, con- captoethanol) containing 0.6 M NaCI. The fractions contain-
ductivity and absorbance at 280 nm. The eluted protein profile ing kinase activity were pooled, adjusted to the conductivity
was analyzed by SDS-PAGE. Fractions containing protein of buffer E + 0.6 M NaCl with buffer E + 4.5 M NaCl and
kinase C activity (Ca2 /PtdSer stimulated above basal) were
+ applied directly to the protamine-agarose column at a flow
pooled in this manner. rate of 25 mlih. The column was washed with 30 ml buffer
Fig. 1. Chromatographicpurificationsteps together with SDS-PAGE. (A) DEAE-Sephacel column chromatography of rat brain soluble proteins.
The 100000 x g supernatant of rat brain extract was applied to a DEAE-cellulose column equilibrated with buffer B. The column was washcd
extensively with buffers B and C. The proteins were eluted with a 0-0.3 M gradient NaCl in buffer C (gradient increases from left to right).
An aliquot from every fifth fraction was assayed in the presence (0--0) or absence (0-0) of Ca2+/PtdSer/diolein.A peak of C a 2 + /
PtdSer/diolein-stimulated activity was found in fractions 24 - 45. (B) SDS-PAGE of DEAE-Sephacel column chromatography. Every fifth
fraction (30 pl) from the DEAE-Sephacel column was analyzed on a 12.5% SDS/polyacrylamide gel. The Coomassie blue-stained gel is shown
with molecular mass markers on left. Fractions 25 -45 correspond to those with the major peak of C kinase activity. (C) Phenyl-Sepharose
CL-4B column chromatography of protein kinase C. DEAE-Sephacel fractions (25 -45) were pooled and applied to a phenyl-Sepharose CL-
4B column equilibrated in buffer D + 1.5 M NaCI. The bound enzyme was eluted from the matrix with a linear gradient of 600-0 mM NaCl
in buffer D, followed by an additional 30 ml buffer D. Every fifth fraction was assayed for C kinase activity in the presence (0-0) or
absence (0-0) of CaZf/PtdSer/diolein.A sharp peak of activity eluted from fractions 35 - 65. Note: the additional wash effectively
removed all bound enzymatic activity. (D) SDS-PAGE of phenyl-Sepharose CL-4B column chromatography. Every fifth fraction (30 pl) from
the phenyl-Sepharose C L 4 B column was analyzed on a 12.5% polyacrylamide gel. The Coomassie-blue-stained gel is shown with molecular
mass markers on left. Fractions 35 -65 correspond to those with the major peak of C kinase activity (pkc). A doublet protein of approximate
molecular mass 77-80 kDa is readily visible at this point. (E) Protamine-agarose column chromatography of protein kinase C. Phenyl-
Sepharose CL-4B fractions 35-65 were pooled and applied to a I-ml protamine-agarose column pre-equilibrated in buffer E. Every third
fraction was assayed for C kinase activity in the presence (0-0) or absence (0-0) of Caz+/PtdSer. Arrow 1 : flow through; arrow
2: buffer E + 600 mM NaCl; arrow 3 : buffer E + 500 mM NaCl, Mg2+/ATP;arrow 4: buffer E + 600 mM NaCI, MgZ+/ATP;arrow 5 : buffer
E + 700 mM NaCI, Mg2+/ATP;arrow 6: buffer E + 1.5 mM NaCI, MgZ+/ATP.A sharp peak of Ca’+/phosphoIipid-dependent activity
eluted immediately after addition of 600 mM NaCl containing MgZ+/ATP.(F) SDS-PAGE of phenyl-Sephdrose CL-4B column chromatog-
raphy. Every third fraction (30 pl) from the protamine-agarose column was analyzed on a 12.5% polyacrylamide gel. The Coomassie-blue-
stained gel is shown with molecular mass markers on left. A doublet 77/80-kDa protein is visualized in fractions containig C kinase activity
(fractions 31 -42)
464
+
E 0.6 M NaCl. Elution from the protamine-agarose resin For Coomassie blue visualization of proteins, the gels were
was accomplished by four successive step-washes consisting stained with 1.5% Coomassie brilliant blue in 45% methanol
+
of 5 ml each of buffer E 10 mM MgC12, 1 mM ATP and (a) and 10% acetic acid, and destained in 12% methanol, 12%
500 mM NaCl; (b) 600 mM NaCl; (c) 700 mM NaCl; and acetic acid. The following marker proteins were used:
(d) 1.5 M NaCl. Fractions of 0.5 ml were collected at the 200 kDa, myosin; 116 kDa, galactosidase; 92 kDa, phosphor-
beginning of the Mg2+/ATPsalt elutions. Both protein kinase ylase b ; 66 kDa, bovine serum albumin; 45 kDa, ovalbumin;
C activity and SDS-PAGE profiles were determined across 31 kDa, carbonic anhydrase; 21 kDa, soybean trypsin in-
the column. hibitor; 14 kDa, lysozyme.
pmol min-' %
mg-
Non-phosphorylated protamine-agarose 3548 f 144 -
Phosphorylated protamine-agarose 367 137 90
Table 3. Effect of H7 on protein kinase C activity Table 4. Effectof H7 on protein kinase C binding to protamine agarose
Protein kinase C activity was assayed with either protamine or histone as assessed by the probe (3H]phorbol 12,lS-dibutyrate
as substrate in the presence or absence of calcium, phosphatidylserine Aliquots of semipurified enzyme were premixed with 0- 100 pM H7
or diolein as described under Materials and Methods. Results are before addition of protamine-agarose beads in suspension in buffer
reported as nmol min-' mg enzyme protein-' and represent the mean E + 0.6 M NaCl. After washing to get rid of non-bound enzyme, the
f 1 standard deviation (SD) of triplicate experiments beads were resuspended in 20 mM Tris, pH 6.8,lOO mM KCl, 0.5 mM
CaClz and 100 pg/ml PtdSer. Reaction volumes were made up to
Incubation Activity Inhibition 100 pl by the addition of 30 mM [3H]phorbol 12,13-dibutyrate
+
- SD (12.5 Ci/mmol) in the presence or absence of a 100-fold excess of non-
labelled phorbol dibutyrate. After 30 min at 30°C the beads were
nmol min-' % washed, transferred to scintillation vials and counted. Radioactivity
mg-' in the presence of unlabelled phorbol dibutyrate was regarded as
6.34T0.830 background and subtracted from estimations obtained in the presence
Protamine -
of label only. All estimates were done in duplicate and are reported
Protamine + C a 2 + ,PtdSer/diolein 11.60 f 2.65 -
asmeans 1 SD
Protamine + H7, 1 pM 5.14+0.791 19
Protamine + H7, 10 pM 3.89 f 0.953 39 Amount of H7 [3H]phorbol
Protamine + H7, 50 pM 2.04 f 0.125 68 12,13-dibutyrate bound
Protamine + H7, 100 pM 2.05 f 0.406 68
Protamine + Ca", PtdSer/diolein PM dPm
+ H 7 , l pM 1.29 & 0.544 37 0 16 769 f 5072
Protamine + C a 2 + ,PtdSer/diolein 1 15711 f 6500
+ H7, 10pM 5.92 f 1.03 49 10 17462 f 4551
Protamine + Ca2+,PtdSer/diolein 100 17921 f 2741
+ H7, 50 pM 3.49 T 0.956 70
Protamine + C a Z f ,PtdSer/diolein
+ H7,lOO p M 2.70 f 0.792 77
Histone 1.53 f0.311 - amount of enzyme bound to the column in the presence or
Histone + C a 2 + ,PtdSer/diolein 13.25f 1.80 - absence of H7 (Table 4).
Histone + C a 2 + ,PtdSer/diolein
+ H 7 , l pM 9.85 0.778 26 DISCUSSION
Histone + C a 2 + ,PtdSer/diolein
+ H7,lO pM 6.60f 1.95 50 Protamine, a highly basic protein, which has been de-
Histone + C a 2 + ,PtdSer/diolein scribed as a specific substrate for protein kinase C [15], was
+ H7, 50 pM 3.03 f 0.40 77 employed for the purification of the enzyme. The three-step
Histone + C a 2 + ,PtdSer/diolein procedure described, provides a comparatively simple method
+ H7,lOO pM 2.50 f 0.665 81
for the preparation of homogeneous protein kinase C. This
method results in adequate yields and permits the use of
purified protein kinase C as a biochemical reagent. Recently
phorylation of protamine was stimulated twofold. These re- described purification procedures [ l l , 121 are costly and time-
sults suggest that protamine may interact with the enzyme in consuming, yielding very low quantities of purified enzyme.
the absence of Ca2+ of phospholipid in such a way that A direct comparison of our purification scheme with other
the active center is triggered to phosphorylate the binding published procedures to obtain homogeneous protein kinase
substrate in the presence of Mg2+ and ATP. Phosphorylation C is presented in Table 5.
of protamine sulfate may in turn be responsible for its release Our purification further substantiates the previous obser-
from the column. To test this hypothesis further, protein vation that protamine kinase and C kinase are one and the
kinase C was bound to protamine agarose in buffer E + 0.6 M same activity [23].Apart from copurification, they had similar
NaCl followed by washing away the unbound protein and peptide maps and similar antigenic properties. The reason for
T Pthe presence of Mg2+.Analysis of appearing as a doublet is uncertain at this stage but could
addition of [ Y - ~ ~ P ] Ain
the phosphorylated products by SDS-PAGE/auto- involve posttranslational modification. Furthermore, this ob-
radiography (Fig. 3) revealed a time-dependent increase in servation was not restricted to brain tissue but applied also
phosphorylation of protamine in situ on the resin (triplet of to spleen (M. Wooten, unpublished results). Moreover, the
bands) as well as slight autophosphorylation on the enzyme properties of our homogeneous preparation are quite similar
itself (top arrow). Moreover, if protamine was phosphorylated to those described for protein kinase C utilizing other tissue
it no longer bound protein kinase C (Table 2). This suggests sources or purification methods [ l l , 121. Likewise, the specific
that the resin may not be used again unless treated with a activity was roughly the same as that obtained by other meth-
phosphatase prior to binding of protein kinase C. ods (4619 or 4135 nmol min-' mg-' respectively) [ll, 121.
H7 has recently been described as a potent and specific Moreover, our data shed light on the manner in which C
inhibitor of protein kinase C [21, 221 and could, therefore, be kinase interacts with protamine. In the absence of Mg2+ and
used to further define the interaction between kinase C and ATP the enzyme is able to bind to immobilized protamine
protamine. Both protamine sulfate and histone type 111-S under the buffer conditions described. When MgZ and ATP +
phosphorylation were inhibited by H7, whether reactions were are supplied, the substrate is phosphorylated and the enzyme
run in the presence or absence of Ca'+/phospholipid (Table released. Because this occurs in a Ca2+/phospholipid-inde-
3 ) . Since H7 was shown to compete with ATP but not substrate pendent manner, it is likely that upon initial binding a
binding to the active center [21, 221, it may be expected not conformational change ensues, which activates the enzyme.
to interfere with C kinase binding to the protamine-agarose This implies at least some interaction with the active center of
column. This notion was confirmed by determining the actual the enzyme, either directly or via a closely associated allosteric
467
effector site. It remains to be proven whether the same pro- 2. Nishizuka, Y. (1984) Nature (Lond.) 308,693-698.
tamine molecule can compensate for putative closely associ- 3. Cooper, R. A., Brunwald, A. D. & Kuo, A. L. (1982) Proc. Nutl
ated PtdSer and Ca2+-bindingsites or whether more complex Acad. Sci. USA 79,2865-2869.
stoichiometric alterations are brought about at more distal 4. Kuo, J. F., Anderson, R. G. G., Wise, B. C., Mackerlova, L.,
Salomonson, J., Brackett, N. L., Katoh, N., Shoji, M. &
sites. C a 2 + , PtdSer and diolein could enhance phos-
Wrenn, R. W. (1980) Proc. Nutl Acad. Sci. U S A 77, 7039 -
phorylation even further, implying that at least some of these 7043.
allosteric binding sites remained unoccupied. 5. Wooten. M. W. & Wrenn, R. W. (1984) FEBS Lett. 171, 183-
Thus far, most inhibitors of protein kinase C interact 186.
directly with the phospholipid-binding site [24, 251. We, how- 6. Wolf, M., Cuatrecasas, P. & Sahyoun, N. (1985) J . Biol. Chem.
ever, demonstrated that H7 inhibits the Ca2+/phospholipid- 260, 15718 - 15722.
independent phosphorylation of protamine. This confirms 7. Ganong, B. R., Loomis, C. R.. Hannun, Y. A. & Bell, R. M.
that H7 interacts with the active center and the protamine (1986) Puoc. Nutl Acud. Sci. U S A 83, 1184-1188.
phosphorylation assay could provide an easy way of 8. Kikkawa, U., Takai, Y., Minakuchi, R., Inohara, S. & Nishizuka,
determining the site of action of putative C kinase inhibitors Y . (1982) J . Bid. Chem. 257, 13341-133348.
9. Wise, B. C. & Kuo, J. F. (1982) J . Bid. Chem. 257, 8481 -8488.
[21, 221. 10. Le Peuch, C. J., Ballester, R. & Rosen, 0 . M. (1983) Proc. Nutl
Considerable attention has been focused on protein kinase Acud. Sci. U S A 80,6858 - 6862.
C in the last few years owing to its regulatory role in diverse 11. Uchida, T. & Filburn, C. R. (1984) J. Bid. Chem. 259, 1231 1 -
cellular processes. With the aid of H7, a specific C kinase 12314.
inhibitor, and studies regarding specific substrate phosphory- 12. Parker, P. J., Stabel, S. & Waterfield, M. D. (1984) EMBO J . 3,
lation we may begin to unravel the complex regulatory role 953-959.
that this kinase system plays in modulating biological 13. Schatzman, R. C., Raynor, R. L., Fritz, R. B. & Kuo, J. F. (1983)
functions. Protamine phosphorylation may be used to screen Biochem. J . 209, 435-443.
possible inhibitors of C kinase operating on its active center 14. Kikkawa, U., Masayoshi, G., Koumoto, J. & Nishizuka, Y.
(1 986) Biochem. Biophys. Res. Commun. 135,636- 643.
and protamine-agarose chromatography can be used to purify 15. Takai, Y., Kishimoto, A,, Iwasa, Y., Kawahara, Y., Mori, T. &
the enzyme in relatively large amounts. Woodgett and Hunter Nishizuka, Y . (1979) J . Biol. Chem. 254, 3692-3695.
[26] have recently described the existance of two forms of 16. Tanaka, Y., Miyake, R., Kikkawa, U. & Nishizuka, Y. (1986) J .
protein kinase C (78 - SO-kDa species). They have provided Biochem. (Tokyo) 99, 257-261.
immunological and physiochemical data supporting the no- 17. Laemmli, U. K. (1970) Nature (Lond.) 277, 680.
tion that isoforms of this protein exist in several tissues. In 18. Cleveland, D. W., Fischer, S. G., Kirschner, M. W. & Laemmli,
further support for the existance of isoforms of the enzyme, U.K.(1977)J. Bid. Chem.252.1102-1106.
analysis of rat brain protein kinase C cDNA clones have 19. Gershoni, J. M. & Palade, G. E. (1983) Anal. Biochem. 131, 1 -
shown that the heterogeneity may be due to alternative 15.
20. Bradford, M. M. (1976) Anal. Biochem. 72,248-254.
splicing [27]. Our data would be in line with these findings. It 21. Hidaka, H., Inagaki, M., Sachiyo, K. & Sasaki, Y. (1984) Bio-
will be of interest to determine whether the two forms are chemistry 23, 5036 - 5041.
preferentially expressed and the possible physiological signifi- 22. Kawamoto, S. & Hidaka, H. (1984) Biochem. Biophys. Res.
cance of this expression. Commun I25,258-264.
23. Inoue, M., Kishimoto, A,, Takai, Y. & Nishizuka, Y. (1977) J .
This work was supported by grants from the South African Medi- Biol. Chem. 252, 7610-7616.
cal Research Council to A. E. Nel and National Cancer Institute (CA- 24. Mori, T., Takai, Y., Minakuchi, R., Yu, B. & Nishizuka, Y.
08038-01) to M. W. Wooten. This work was completed in partial (1980) J . Bid. Chum. 255, 8378 - 8380.
fulfillment of a doctoral thesis (M. V.). We would like to thank Mrs 25. Katoh, N., Raynor, R. L., Wise, €3. C., Schatzman, R. C., Turner,
W. Visser for skilful secretarial assistance. R. S., Helfman, D. M., Fain, J. F. & Kuo, J. F. (1982) Biochem.
J . 202,217-224.
26. Woodgett, J . R. &Hunter, T. (1987) Mol. Cell. Biol., in the press.
REFERENCES 27. Ono, Y., Kurokawa, T., Kawahara, K., Nishimura, O.,
Marumoto, R., Igarashi, K., Sugino, Y., Kikkawa, U., Ogiga,
1. Nishizuka, Y. (1984) Science (Wash. D C ) 225, 1365-1370. K. & Nishizuka, Y . (1986) FEBS Lett. 203, 111 -115.